ClinConnect ClinConnect Logo
Search / Trial NCT06979245

Turkish Adaptation of the VascuQoL-6 Quality of Life Scale

Launched by UŞAK UNIVERSITY · May 11, 2025

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Takayasu Arteritis Behcet Disease Turkish Validity Reliability Quality Of Life

ClinConnect Summary

Takayasu arteritis (TA) is a rare, systemic granulomatous large vessel vasculitis that primarily affects the aorta and its branches. Although all major arteries can be affected, the descending and ascending aorta, subclavian arteries, and carotid arteries are most commonly affected. Inflammation can lead to intimal proliferation and stenosis or destruction of the vascular structure and aneurysmal degeneration. TA is a disease with profound consequences on quality of life.

Behçet's disease is a multisystemic, chronic inflammatory vasculitis characterized by skin and mucosal lesions.

The va...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 18-65
  • Being willing to participate in the study
  • Being diagnosed with Takayasu Arteritis or Vascular Behçet's disease by a rheumatologist
  • Exclusion Criteria:
  • Having another disease that will affect their physical condition
  • Having a cognitive disability that will prevent them from cooperating
  • Being pregnant
  • Having a neurological disease (hemiplegia, Parkinson's, multiple sclerosis, vertigo, epilepsy, etc.)
  • Having undergone any surgery in the last year
  • Having another simultaneous rheumatic disease

About Uşak University

Uşak University is a distinguished academic institution dedicated to advancing research and education in various fields, including the health sciences. As a clinical trial sponsor, Uşak University is committed to fostering innovation and contributing to medical knowledge through rigorous scientific investigation. The university collaborates with healthcare professionals and researchers to conduct high-quality clinical trials that aim to improve patient outcomes and enhance therapeutic interventions. With a focus on ethical standards and regulatory compliance, Uşak University strives to ensure the integrity and reliability of its research initiatives, ultimately benefiting the broader community and the advancement of healthcare practices.

Locations

Denizli, , Turkey

Denizli, , Turkey

Patients applied

0 patients applied

Trial Officials

Bilge Basakcı Calık, Prof. Dr.

Principal Investigator

Pamukkale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported